Uae Wound Care Management Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Uae Wound Care Management Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The UAE wound care management market is expected to register a CAGR of 6.89% during the forecast period (2022-2027).

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to ​reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. According to the UAE Healthcare Perspectives published in September 2020, around 28 million elective surgery operations were canceled or postponed over the world. The Dubai Health Authority in its circular published in June 2021 instructed the hospitals in the United Arab Emirates to cease all elective therapeutic surgeries that require deep sedation or general anesthesia, with the exception of medical urgency and necessity as indicated by the treating physician. The large number of surgeries piled up in the medical sector is likely to add to the growth of surgical wound care management over the forecast period.

The International Inter-Professional Wound Care Group conducted the tenth wound care conference, World Union of Wound Healing Societies (WUWHS) 2022 HYBRID CONGRESS in Abu Dhabi in March 2022. The conference aims to promote greater collaboration and cooperation of all the Scientific Wound Care Societies around the world. Such conferences focusing on the necessity of wound care management in the nation are expected to boost the growth of the market over the forecast period.

The propelling factors for the growth of the UAE wound care management market includes the growing demand for faster recovery of wounds, rising incidence of chronic wound, and an increase in the number of surgeries.

The rising incidences of chronic wounds impose a significant burden on the individual, the healthcare system, and society as a whole. In the Middle East, the prevalence of diabetes is among the highest in the world, which is estimated to be around 12-20% of the overall population in the region.

The incidences of chronic wounds, especially foot ulcers, are common among the diabetic population. According to the February 2022 update by the International Diabetes Federation, around 12.3%, accounting for 990,900 people of the total population in the United Arab Emirates are affected by diabetes. Therefore, the number of diabetic patients is expected to increase with the rising geriatric population, which in turn will drive the market for wound care management in the forecast period.

In addition, an increase in the surgical procedures along with the increasing aging population is also fuelling the growth of the wound care management market. Furthermore, owing to the rapid evolution of the market in the use of wound closure devices, medical device companies are able to launch new innovative equipment which will be rewarded with huge benefits.

Foam dressing is found to play a significant role in the clinical management of chronic wounds and in moist wound healing. They are found to be produced with variable thickness and may be adhesive or non-adhesive. The foam dressing market is also growing due to the management of chronic wounds that play a significant medical burden associated with large healthcare expenditures.

As per the Telecommunications and Digital Health Regulatory Authority data 2020 on the United Arab Emirates, the UAE government spent around AED 4.84 billion in the year 2020 on healthcare. This was an increase of 9.09% from the previous year. The healthcare expenditure includes diabetic foot and wound care surgeries performed by hospitals in the United Arab Emirates for UAE nationals. The rise in healthcare expenditure in the nation is likely to propel the growth of the UAE wound care management market over the forecast period.

Various key market players are also playing a significant role in the growth of the wound care management market in the nation. In December 2020, MediWound Ltd. expanded its NexoBrid global presence and entered the Middle Eastern markets with the signing of a distribution agreement granting Ghassan Aboud Group (GAG), an international conglomerate based in the United Arab Emirates (UAE). NexoBrid is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours of application without harming viable tissue. Such product launches in the nation are expected to boost the growth of the market over the forecast period.

The UAE wound care management market is fragmented competitive and consists of several major players. The continuous development of new products provides end users with advanced options for wound treatment (especially in the case of hard-to-heal wounds) that helps in the growth of the market. Some of the companies which are currently dominating the market are Medtronic Plc, 3M Company, Smith & Nephew Plc, ConvaTec Inc, Beiersdorf AG, Coloplast A/S and Molnlycke Health Care.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support